Condition
Renal Failure
ClinicalTrials.gov condition label
Clinical trials
60 shownPrevent Cardiac Surgery Associated AKI TrialNCT06620523 · 2024-07-18
RECRUITINGSGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With PrediabetesNCT06054035 · 2023-10-26
RECRUITINGSCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)NCT04589065 · 2025-09-01
SUSPENDEDNear-Infrared Spectroscopy Measurements in Chronic Obstructive Pulmonary DiseaseNCT06976762 · 2025-05-01
ENROLLING_BY_INVITATIONIntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.NCT06599424 · 2023-10-01
UNKNOWNImproving Patient Prioritization During Hospital-homecare TransitionNCT04136951 · 2023-08-01
COMPLETEDComparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)NCT05797649 · 2023-07-01
COMPLETEDExternal Validation of the VExUS Score for the Prediction of Acute Renal Failure in Cardiac SurgeryNCT05640518 · 2022-12-19
UNKNOWNAdvancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient OutcomesNCT05443321 · 2022-11-01
ENROLLING_BY_INVITATIONThe Effect of Using Virtual Reality Glasses on Post-Care Pain and Comfort Level in Intensive Care PatientsNCT06923982 · 2022-07-01
COMPLETEDBaromètre Santé Adulte 2021-2022NCT05218304 · 2021-07-26
SUSPENDEDSELF-BREATHE RCT for Chronic BreathlessnessNCT04574050 · 2021-01-11
COMPLETEDOutcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and WalesNCT04838106 · 2020-08-01
UNKNOWNBiomarkers, Genomics, Physiology in Critically Ill and ECMO PatientsNCT04669444 · 2020-04-14
UNKNOWNKidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.NCT05662267 · 2020-03-10
COMPLETEDPersonalized Experiences to Inform Improved Communication for Patients With Life Limiting IllnessNCT04118569 · 2019-10-01
COMPLETEDSafety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical ConditionsNCT03899298 · 2019-09-01
NOT_YET_RECRUITINGA Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacyNCT03834207 · 2018-10-01
UNKNOWNA Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney FunctionNCT03332186 · 2018-03-15
COMPLETEDVasQ External Support for Arteriovenous FistulaNCT03242343 · 2017-11-29
COMPLETEDEffect of Haemodialysis on the Efficacy of Antiplatelet AgentsNCT03330223 · 2017-11-10
UNKNOWNThe Effects of Hemodialysis on Serum Sclerostin LevelsNCT03952819 · 2017-09-14
COMPLETEDCan Urinary Concentrations of TIMP2 and IGFBP7 be Used to Predict Early Acute Renal Failure Following Cardiac Arrest?NCT03211962 · 2017-02-01
COMPLETEDThe Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study IIINCT02973243 · 2016-10-05
COMPLETEDStudy of the Effect on Clinical Outcomes Using Secure Text MessagingNCT02568514 · 2016-08-01
WITHDRAWNGLP-1 and Hyperoxia for Organ Protection in Heart SurgeryNCT02673931 · 2016-02-01
UNKNOWNIncisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled TrialNCT03010137 · 2015-12-01
TERMINATEDRRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.NCT02325726 · 2014-09-01
COMPLETEDObesity Surgery and Kidney Transplant for Patients With Obesity and Renal FailureNCT02128802 · 2014-04-01
COMPLETEDProtocolized Diuretic Strategy in Cardiorenal FailureNCT01921829 · 2013-11-01
TERMINATEDInert Gas Rebreathing in Ventilated PatientsNCT01891253 · 2013-03-01
UNKNOWNThe Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal FailureNCT01937858 · 2012-07-01
TERMINATEDRemote Ischemic Preconditioning in High Risk Cardiovascular Surgery PatientsNCT01328912 · 2012-02-01
COMPLETEDMR-Evaluation of Renal Function-After-Pancreas-transplantationNCT01537445 · 2012-02-01
UNKNOWNErythropoietin (EPO) to Protect Renal Function After Cardiac SurgeryNCT01423955 · 2011-10-01
COMPLETEDAdherence Enhancement for Renal Transplant PatientsNCT01859273 · 2011-09-01
COMPLETEDVeliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionNCT01366144 · 2011-06-20
ACTIVE_NOT_RECRUITINGStudy to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)NCT02019342 · 2011-06-01
WITHDRAWNPrognostic Indicators as Provided by the EPIC ClearViewNCT01476995 · 2010-09-01
COMPLETEDStudy of an Intervention to Improve Problem List Accuracy and UseNCT01105923 · 2010-05-01
UNKNOWNA Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?NCT01009229 · 2009-06-01
COMPLETEDThe Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal FailureNCT00613964 · 2009-05-01
TERMINATEDUsing AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically IllNCT01073800 · 2009-04-01
COMPLETEDFluid Management in the Post-Anesthetic Care Unit (PACU) at Sourasky Medical CenterNCT00995228 · 2009-03-01
UNKNOWNUremic Toxins in the ICU: Patients After Cardiac SurgeryNCT00752804 · 2008-07-31
COMPLETEDAssessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline InfusionNCT00696605 · 2008-07-01
COMPLETEDNephrogenic Systemic Fibrosis With GadollinumNCT01359345 · 2008-07-01
UNKNOWNCardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney DonationNCT01564966 · 2008-04-01
COMPLETEDHemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement RxNCT00666003 · 2008-04-01
COMPLETEDHypertonic Saline Solution in Heart FailureNCT00555685 · 2008-02-01
COMPLETEDSequential Cystatin C Levels and Renal Impairment in Acute Heart FailureNCT00561483 · 2007-12-05
COMPLETEDCoronary Artery Disease and Renal Failure RegistryNCT00679419 · 2007-12-01
UNKNOWNPrevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDPNCT00584350 · 2007-11-01
UNKNOWNAdaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary SyndromeNCT00412802 · 2006-12-01
COMPLETEDAttenuation of Cardiac Effects of Arteriovenous Fistula Creation With LosartanNCT00602004 · 2006-10-01
COMPLETEDNatrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMACNCT00338455 · 2006-09-01
TERMINATEDThe Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFRNCT00470769 · 2006-09-01
UNKNOWNStudy of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal DamageNCT00313807 · 2005-11-01
WITHDRAWNUse of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure PatientsNCT00466882 · 2005-10-17
WITHDRAWNAutonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal DiseaseNCT00298129 · 2004-02-01
COMPLETEDCommon interventions
PlaceboDRUG420% Human AlbuminDRUG1AcetylcysteineDRUG1Ambulatory blood pressure monitoringDEVICE1Amino AcidDRUG1Amniotic and Umbilical Cord Tissue ProcedureBIOLOGICAL1Analysis of urinary levels of TIMP2 and IGFBP7 within 6 hours after cardiac circulatory arrestOTHER1atorvastatin 80 mg per os dailyDRUG1Automatic RR MeasurementDEVICE1Blood sampleBIOLOGICAL1BMS-986231DRUG1Byetta (Lilly, Exenatide)DRUG1CarboplatinDRUG1Carperitide heart failure therapyDRUG1Clopidogrel group;Ticagrelor groupDEVICE1Color-Doppler Ultrasound, 99mTc-DTPA scintigraphyPROCEDURE1Conoxia (AGA, oxygen)DRUG1controlOTHER1control groupOTHER1CoQ10 1200 mg orally with Glutathione 1000 mg orallyDRUG1Cyclosporine discontinuationDRUG1Dapagliflozin (Forxiga®)DRUG1DermabondDEVICE1Dialysis during 4 hoursPROCEDURE1Dialysis during 6 hoursPROCEDURE1
Leading sponsors
Brigham and Women's Hospital2Queen's University2Yokohama City University Medical Center2Abant Izzet Baysal University1Agence Sanitaire et Sociale de Nouvelle Calédonie1Baystate Medical Center1Bristol-Myers Squibb1Çankırı Karatekin University1Centre Hospitalier Universitaire, Amiens1Chinese University of Hong Kong1Columbia University1Copenhagen University Hospital, Rigshospitalet1Dr Christopher Marguerie1Epic Research & Diagnostics, Inc.1French Cardiology Society1
Trial status mix
COMPLETED34
UNKNOWN16
TERMINATED5
WITHDRAWN4
ENROLLING_BY_INVITATION2
RECRUITING2
SUSPENDED2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
Phase mix
NA21
PHASE48
PHASE27
PHASE34
PHASE13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.